Your browser doesn't support javascript.
loading
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
Tachihara, Motoko; Negoro, Shunichi; Inoue, Takako; Tamiya, Motohiro; Akazawa, Yuki; Uenami, Takeshi; Urata, Yoshiko; Hattori, Yoshihiro; Hata, Akito; Katakami, Nobuyuki; Yokota, Soichiro.
Afiliación
  • Tachihara M; Department of Respiratory Medicine, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-Cho, Chuo-Ku, Kobe-city, Hyogo, 650-0017, Japan. mt0318@med.kobe-u.ac.jp.
  • Negoro S; Department of Medical Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-shi, Hyogo, 673-8558, Japan.
  • Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka-shi, Osaka, 541-8567, Japan.
  • Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka-shi, Osaka, 541-8567, Japan.
  • Akazawa Y; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.
  • Uenami T; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.
  • Urata Y; Department of Thoracic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-shi, Hyogo, 673-8558, Japan.
  • Hattori Y; Department of Thoracic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-shi, Hyogo, 673-8558, Japan.
  • Hata A; Department of Medical Oncology, Kobe City Medical Center General Hospital, 2-1-1 2 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
  • Katakami N; Department of Medical Oncology, Kobe City Medical Center General Hospital, 2-1-1 2 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
  • Yokota S; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.
BMC Cancer ; 18(1): 946, 2018 Oct 03.
Article en En | MEDLINE | ID: mdl-30285770
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Japón